Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01899417 · ClinicalTrials.gov registry record
Costs and Benefits of ConforMIS iTotal® Knee Replacement System Versus Standard Total Knee
A clinical trial, sponsored by Restor3D.
- Completed
- Registry status
- 235
- Enrollment target
NCT01899417: Completed study, sponsored by Restor3D.
NCT01899417 is a clinical trial that has completed, run by Restor3D. The registered enrollment target is 235 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01899417 has completed, sponsored by Restor3D.
- COMPLETED
- Registry status
- 235 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the costs and benefits of the ConforMIS iTotal® total knee replacement system versus standard total knee arthroplasty. This study is designed to illustrate the difference in cost between standard total knee replacements and the ConforMIS iTotal at a single institution.
Primary Outcome
Fixed and variable costs resulting from Total Knee Arthroplasty at 30 days post-op
Interventions
- DEVICE ConforMIS iTotal® Knee Replacement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 235 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-03 |
What the finished NCT01899417 record still lists
NCT01899417 is an observational study that tracks outcomes without assigning an intervention. The registered 235 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which ConforMIS iTotal® Knee Replacement is the first listed.
NCT01899417 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01899417 about?
NCT01899417 is a clinical study titled "Costs and Benefits of ConforMIS iTotal® Knee Replacement System Versus Standard Total Knee". The purpose of this study is to evaluate the costs and benefits of the ConforMIS iTotal® total knee replacement system versus standard total knee arthroplasty. This study is designed to illustrate the difference in cost between standard total knee replacements and the ConforMIS iTotal at a single i...
What is the current status of trial NCT01899417?
This trial is currently completed. The enrollment target is 235 participants. The study started on 2013-07. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01899417?
The interventions under investigation include: ConforMIS iTotal® Knee Replacement (DEVICE).
Who is sponsoring clinical trial NCT01899417?
This trial is sponsored by Restor3D, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01524211 · 235 participants · NA
Evaluation of Branch Endografts in the Treatment of Aortic Aneurysms
- NCT05316155 · 235 participants · Phase 1
Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer
- NCT05353569 · 235 participants · NA
Coherent Optical Detection of Middle Ear Disease
- NCT05390918 · 235 participants · NA
Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia